Sonal Parasrampuria, MPH, PhD is a health economist in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) who serves as the FDA team lead and works on research related to drug pricing. Previously, Sonal was an economist at the Innovation Center within CMS, focusing on Part D models. Her research has centered on ensuring access to health care services through adequately generous government programs. Sonal received a PhD from the Johns Hopkins Bloomberg School of Public Health. She also holds an MPH from Columbia University’s School of Public Health and a BA with Honors from Swarthmore College.